Pfizer reports loss on hit from one-time clinical failures
Business
Finance
Health
August 4, 2026
Share this article
Click to view full size
NEW YORK, United States (AFP) — Pfizer reported a second-quarter loss Tuesday following writedowns due to unfavorable clinical results despite scoring higher overall sales.
The drugmaker’s loss of $248 million compared with profits of $2.9 billion in the year-ago period, while revenues rose three per cent to $15.0 billion.
Pfizer pointed to revenue growth from blood thinner Eliquis, cancer treatment Padcev and the heart drug Vyndaqel.
Business
Finance
Health
Need the bigger picture?
Share this article
Comments (0)
Download our mobile app
The portable companion to gazettE. Get notifications, track read articles, and more. The latest news from Trinidad and Tobago, in one place.
